CBA Pharma, Inc.
Records under this name other than the patents CBA Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Showing 1 to 9 of 9 · Back to CBA Pharma, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,962,927 | Method for potentiating primary drugs in treating multidrug resistant disease Term ended Term ended Nov 8, 2022 · From the USPTO record | Term ended | Term ended Nov 8, 2022 | From the USPTO record |
| US 6,911,454 | Method for potentiating primary drugs in treating multidrug resistant disease Term ended Term ended Jun 28, 2022 · From the USPTO record | Term ended | Term ended Jun 28, 2022 | From the USPTO record |
| US 8,609,844 | Method for extracting and purifying bisbenzylisoquinolines Formerly held Lapsed on the fee record Ended Dec 17, 2021 · From the USPTO record | Lapsed on the fee record | Ended Dec 17, 2021 | From the USPTO record |
| US 9,745,269 | Supercritical fluid extraction of bis-benzyl isoquinolines Lapsed on the fee record Ended Aug 29, 2021 · From the USPTO record | Lapsed on the fee record | Ended Aug 29, 2021 | From the USPTO record |
| US 6,528,519 | Use of tetrandrine and its derivatives to treat malaria Term ended Term ended Mar 4, 2020 · From the USPTO record | Term ended | Term ended Mar 4, 2020 | From the USPTO record |
| US 6,218,541 | Method for extracting bisbenzylisoquinolines Term ended Term ended Jun 28, 2019 · From the USPTO record | Term ended | Term ended Jun 28, 2019 | From the USPTO record |
| US 6,124,315 | Method for potentiating primary drugs in treating multidrug resistant disease Term ended Term ended Sep 26, 2017 · From the USPTO record | Term ended | Term ended Sep 26, 2017 | From the USPTO record |
| US 5,025,020 | Use of tetrandrine and its derivatives to treat malaria Term ended Term ended no later than Jun 18, 2011 · Low confidence | Term ended | Term ended no later than Jun 18, 2011 | Low confidence |
| US 5,332,747 | Method for potentiating primary drugs in treating multidrug resistant parasitic disease cells Term ended Term ended no later than Jul 26, 2014 · Low confidence | Term ended | Term ended no later than Jul 26, 2014 | Low confidence |